首页> 美国卫生研究院文献>SpringerPlus >Ganoderma formosanum polysaccharides attenuate Th2 inflammation and airway hyperresponsiveness in a murine model of allergic asthma
【2h】

Ganoderma formosanum polysaccharides attenuate Th2 inflammation and airway hyperresponsiveness in a murine model of allergic asthma

机译:福建灵芝多糖减轻过敏性哮喘小鼠模型中的Th2炎症和气道高反应性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Allergic asthma is an inflammatory disease of the airways mediated by Th2 immune responses and characterized by airway hyperresponsiveness (AHR). Fungi of the genus Ganoderma are basidiomycetes that have been used in traditional Asian medicine for centuries. We recently found that PS-F2, a polysaccharide fraction purified from the submerged culture broth of Ganoderma formosanum, stimulates the activation of dendritic cells and primes a T helper 1 (Th1)-polarized adaptive immune response. This study was designed to investigate whether the Th1 adjuvant properties of PS-F2 could suppress the development of allergic asthma in a mouse model. BALB/c mice were sensitized by repeated immunization with chicken ovalbumin (OVA) and alum, followed by intranasal challenge of OVA to induce acute asthma. PS-F2 administration during the course of OVA sensitization and challenge effectively prevented AHR development, OVA-specific IgE and IgG1 production, bronchial inflammation, and Th2 cytokine production. Our data indicate that PS-F2 has a potential to be used for the prevention of allergic asthma.Electronic supplementary materialThe online version of this article (doi: 10.1186/2193-1801-3-297) contains supplementary material, which is available to authorized users.
机译:过敏性哮喘是由Th2免疫反应介导的气道炎症性疾病,其特征是气道高反应性(AHR)。灵芝属真菌是担子菌,已经在传统的亚洲医学中使用了几个世纪。我们最近发现,PS-F2是从灵芝水下培养液中纯化的多糖级分,可刺激树突状细胞的激活并引发T辅助细胞1(Th1)极化的适应性免疫反应。这项研究旨在调查PS-F2的Th1佐剂特性是否可以抑制小鼠模型中过敏性哮喘的发展。通过用鸡卵清蛋白(OVA)和明矾反复免疫,然后经鼻内OVA激发诱发急性哮喘,使BALB / c小鼠致敏。在OVA致敏和攻击过程中给予PS-F2有效预防了AHR的发展,OVA特异性IgE和IgG1的产生,支气管炎症和Th2细胞因子的产生。我们的数据表明PS-F2具有预防过敏性哮喘的潜力电子补充材料本文的在线版本(doi:10.1186 / 2193-1801-3-297)包含补充材料,授权使用用户。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号